Brief: TELA Bio Q4 Revenue USD 16.998 Million Vs. IBES Estimate USD 16.4 Million
21/03/2024 20:05
Mar 21 (Reuters) - TELA Bio Q4 basic EPS USD -0.53. * Q4 net income USD -12.89 million * Q4 operating expenses USD 23.902 million * Q4 income from operations USD -12.278 million * Q4 gross profit USD 11.624 million * outlook FY revenue USD 74-76 million
Recent news on TELA Bio
See all newsBrief: Tela Bio - Receives FDA 510(K) Clearance For Liora Monofilament Scaffold For Soft Tissue Reinforcement
Tela Bio Inc Reports Results For The Quarter Ended June 30: Earnings Summary
TELA Bio Q2 revenue falls on lower OviTex PRS volumes, withdraws outlook
Brief: TELA Bio Q2 Revenue USD 19.291 Million Vs. IBES Estimate USD 20 Million
Tela Bio Inc Expected To Post A Loss Of 18 Cents A Share: Earnings Preview